MpzR98C arrests Schwann cell development in a mouse model of early-onset Charcot-Marie-Tooth disease type 1B

Mario A C Saporta, Brian R. Shy, Agnes Patzko, Yunhong Bai, Maria Pennuto, Cinzia Ferri, Elisa Tinelli, Paola Saveri, Dan Kirschner, Michelle Crowther, Cherie Southwood, Xingyao Wu, Alexander Gow, M. Laura Feltri, Lawrence Wrabetz, Michael E. Shy

Research output: Contribution to journalArticle

Abstract

Mutations in myelin protein zero (MPZ) cause Charcot-Marie-Tooth disease type 1B. Many dominant MPZ mutations, including R98C, present as infantile onset dysmyelinating neuropathies. We have generated an R98C 'knock-in' mouse model of Charcot-Marie-Tooth type 1B, where a mutation encoding R98C was targeted to the mouse Mpz gene. Both heterozygous (R98C/ +) and homozygous (R98C/R98C) mice develop weakness, abnormal nerve conduction velocities and morphologically abnormal myelin; R98C/R98C mice are more severely affected. MpzR98C is retained in the endoplasmic reticulum of Schwann cells and provokes a transitory, canonical unfolded protein response. Ablation of Chop, a mediator of the protein kinase RNA-like endoplasmic reticulum kinase unfolded protein response pathway restores compound muscle action potential amplitudes of R98C/ + mice but does not alter the reduced conduction velocities, reduced axonal diameters or clinical behaviour of these animals. R98C/R98C Schwann cells are developmentally arrested in the promyelinating stage, whereas development is delayed in R98C/ + mice. The proportion of cells expressing c-Jun, an inhibitor of myelination, is elevated in mutant nerves, whereas the proportion of cells expressing the promyelinating transcription factor Krox-20 is decreased, particularly in R98C/R98C mice. Our results provide a potential link between the accumulation of MpzR98C in the endoplasmic reticulum and a developmental delay in myelination. These mice provide a model by which we can begin to understand the early onset dysmyelination seen in patients with R98C and similar mutations.

Original languageEnglish
Pages (from-to)2032-2047
Number of pages16
JournalBrain
Volume135
Issue number7
DOIs
Publication statusPublished - 2012

Fingerprint

Charcot-Marie-Tooth Disease
Schwann Cells
Myelin P0 Protein
Endoplasmic Reticulum
Unfolded Protein Response
Mutation
Early Growth Response Protein 2
Animal Behavior
Neural Conduction
Myelin Sheath
Protein Kinases
Action Potentials
Tooth
Phosphotransferases
RNA
Muscles

Keywords

  • Charcot-Marie-Tooth type 1B
  • Demyelination
  • Glial cells
  • Neuromuscular disorders
  • Neuropathy

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Saporta, M. A. C., Shy, B. R., Patzko, A., Bai, Y., Pennuto, M., Ferri, C., ... Shy, M. E. (2012). MpzR98C arrests Schwann cell development in a mouse model of early-onset Charcot-Marie-Tooth disease type 1B. Brain, 135(7), 2032-2047. https://doi.org/10.1093/brain/aws140

MpzR98C arrests Schwann cell development in a mouse model of early-onset Charcot-Marie-Tooth disease type 1B. / Saporta, Mario A C; Shy, Brian R.; Patzko, Agnes; Bai, Yunhong; Pennuto, Maria; Ferri, Cinzia; Tinelli, Elisa; Saveri, Paola; Kirschner, Dan; Crowther, Michelle; Southwood, Cherie; Wu, Xingyao; Gow, Alexander; Feltri, M. Laura; Wrabetz, Lawrence; Shy, Michael E.

In: Brain, Vol. 135, No. 7, 2012, p. 2032-2047.

Research output: Contribution to journalArticle

Saporta, MAC, Shy, BR, Patzko, A, Bai, Y, Pennuto, M, Ferri, C, Tinelli, E, Saveri, P, Kirschner, D, Crowther, M, Southwood, C, Wu, X, Gow, A, Feltri, ML, Wrabetz, L & Shy, ME 2012, 'MpzR98C arrests Schwann cell development in a mouse model of early-onset Charcot-Marie-Tooth disease type 1B', Brain, vol. 135, no. 7, pp. 2032-2047. https://doi.org/10.1093/brain/aws140
Saporta, Mario A C ; Shy, Brian R. ; Patzko, Agnes ; Bai, Yunhong ; Pennuto, Maria ; Ferri, Cinzia ; Tinelli, Elisa ; Saveri, Paola ; Kirschner, Dan ; Crowther, Michelle ; Southwood, Cherie ; Wu, Xingyao ; Gow, Alexander ; Feltri, M. Laura ; Wrabetz, Lawrence ; Shy, Michael E. / MpzR98C arrests Schwann cell development in a mouse model of early-onset Charcot-Marie-Tooth disease type 1B. In: Brain. 2012 ; Vol. 135, No. 7. pp. 2032-2047.
@article{96b6c60778124bb5a2cf42a76870cae4,
title = "MpzR98C arrests Schwann cell development in a mouse model of early-onset Charcot-Marie-Tooth disease type 1B",
abstract = "Mutations in myelin protein zero (MPZ) cause Charcot-Marie-Tooth disease type 1B. Many dominant MPZ mutations, including R98C, present as infantile onset dysmyelinating neuropathies. We have generated an R98C 'knock-in' mouse model of Charcot-Marie-Tooth type 1B, where a mutation encoding R98C was targeted to the mouse Mpz gene. Both heterozygous (R98C/ +) and homozygous (R98C/R98C) mice develop weakness, abnormal nerve conduction velocities and morphologically abnormal myelin; R98C/R98C mice are more severely affected. MpzR98C is retained in the endoplasmic reticulum of Schwann cells and provokes a transitory, canonical unfolded protein response. Ablation of Chop, a mediator of the protein kinase RNA-like endoplasmic reticulum kinase unfolded protein response pathway restores compound muscle action potential amplitudes of R98C/ + mice but does not alter the reduced conduction velocities, reduced axonal diameters or clinical behaviour of these animals. R98C/R98C Schwann cells are developmentally arrested in the promyelinating stage, whereas development is delayed in R98C/ + mice. The proportion of cells expressing c-Jun, an inhibitor of myelination, is elevated in mutant nerves, whereas the proportion of cells expressing the promyelinating transcription factor Krox-20 is decreased, particularly in R98C/R98C mice. Our results provide a potential link between the accumulation of MpzR98C in the endoplasmic reticulum and a developmental delay in myelination. These mice provide a model by which we can begin to understand the early onset dysmyelination seen in patients with R98C and similar mutations.",
keywords = "Charcot-Marie-Tooth type 1B, Demyelination, Glial cells, Neuromuscular disorders, Neuropathy",
author = "Saporta, {Mario A C} and Shy, {Brian R.} and Agnes Patzko and Yunhong Bai and Maria Pennuto and Cinzia Ferri and Elisa Tinelli and Paola Saveri and Dan Kirschner and Michelle Crowther and Cherie Southwood and Xingyao Wu and Alexander Gow and Feltri, {M. Laura} and Lawrence Wrabetz and Shy, {Michael E.}",
year = "2012",
doi = "10.1093/brain/aws140",
language = "English",
volume = "135",
pages = "2032--2047",
journal = "Brain",
issn = "0006-8950",
publisher = "Oxford University Press",
number = "7",

}

TY - JOUR

T1 - MpzR98C arrests Schwann cell development in a mouse model of early-onset Charcot-Marie-Tooth disease type 1B

AU - Saporta, Mario A C

AU - Shy, Brian R.

AU - Patzko, Agnes

AU - Bai, Yunhong

AU - Pennuto, Maria

AU - Ferri, Cinzia

AU - Tinelli, Elisa

AU - Saveri, Paola

AU - Kirschner, Dan

AU - Crowther, Michelle

AU - Southwood, Cherie

AU - Wu, Xingyao

AU - Gow, Alexander

AU - Feltri, M. Laura

AU - Wrabetz, Lawrence

AU - Shy, Michael E.

PY - 2012

Y1 - 2012

N2 - Mutations in myelin protein zero (MPZ) cause Charcot-Marie-Tooth disease type 1B. Many dominant MPZ mutations, including R98C, present as infantile onset dysmyelinating neuropathies. We have generated an R98C 'knock-in' mouse model of Charcot-Marie-Tooth type 1B, where a mutation encoding R98C was targeted to the mouse Mpz gene. Both heterozygous (R98C/ +) and homozygous (R98C/R98C) mice develop weakness, abnormal nerve conduction velocities and morphologically abnormal myelin; R98C/R98C mice are more severely affected. MpzR98C is retained in the endoplasmic reticulum of Schwann cells and provokes a transitory, canonical unfolded protein response. Ablation of Chop, a mediator of the protein kinase RNA-like endoplasmic reticulum kinase unfolded protein response pathway restores compound muscle action potential amplitudes of R98C/ + mice but does not alter the reduced conduction velocities, reduced axonal diameters or clinical behaviour of these animals. R98C/R98C Schwann cells are developmentally arrested in the promyelinating stage, whereas development is delayed in R98C/ + mice. The proportion of cells expressing c-Jun, an inhibitor of myelination, is elevated in mutant nerves, whereas the proportion of cells expressing the promyelinating transcription factor Krox-20 is decreased, particularly in R98C/R98C mice. Our results provide a potential link between the accumulation of MpzR98C in the endoplasmic reticulum and a developmental delay in myelination. These mice provide a model by which we can begin to understand the early onset dysmyelination seen in patients with R98C and similar mutations.

AB - Mutations in myelin protein zero (MPZ) cause Charcot-Marie-Tooth disease type 1B. Many dominant MPZ mutations, including R98C, present as infantile onset dysmyelinating neuropathies. We have generated an R98C 'knock-in' mouse model of Charcot-Marie-Tooth type 1B, where a mutation encoding R98C was targeted to the mouse Mpz gene. Both heterozygous (R98C/ +) and homozygous (R98C/R98C) mice develop weakness, abnormal nerve conduction velocities and morphologically abnormal myelin; R98C/R98C mice are more severely affected. MpzR98C is retained in the endoplasmic reticulum of Schwann cells and provokes a transitory, canonical unfolded protein response. Ablation of Chop, a mediator of the protein kinase RNA-like endoplasmic reticulum kinase unfolded protein response pathway restores compound muscle action potential amplitudes of R98C/ + mice but does not alter the reduced conduction velocities, reduced axonal diameters or clinical behaviour of these animals. R98C/R98C Schwann cells are developmentally arrested in the promyelinating stage, whereas development is delayed in R98C/ + mice. The proportion of cells expressing c-Jun, an inhibitor of myelination, is elevated in mutant nerves, whereas the proportion of cells expressing the promyelinating transcription factor Krox-20 is decreased, particularly in R98C/R98C mice. Our results provide a potential link between the accumulation of MpzR98C in the endoplasmic reticulum and a developmental delay in myelination. These mice provide a model by which we can begin to understand the early onset dysmyelination seen in patients with R98C and similar mutations.

KW - Charcot-Marie-Tooth type 1B

KW - Demyelination

KW - Glial cells

KW - Neuromuscular disorders

KW - Neuropathy

UR - http://www.scopus.com/inward/record.url?scp=84863203827&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863203827&partnerID=8YFLogxK

U2 - 10.1093/brain/aws140

DO - 10.1093/brain/aws140

M3 - Article

C2 - 22689911

AN - SCOPUS:84863203827

VL - 135

SP - 2032

EP - 2047

JO - Brain

JF - Brain

SN - 0006-8950

IS - 7

ER -